Figure 5.

Comparative analysis of hematological and biochemical parameters following MTBE and MMP administration. A. Total WBC count and WBC fractions (neutrophils, lymphocytes, monocytes, eosinophils and basophils) measured using an automated hematology analyzer post-administration of MTBE and MMP. No significant increases were observed compared to the control group. B. Biochemical analysis of liver and kidney function markers (AST, ALT, creatinine, total bilirubin) across different treatment groups, showing no significant differences. C. Measurement of inflammatory cytokines IL-6 and TNF-α levels using ELISA to evaluate potential inflammatory responses. No significant increase in cytokine levels was observed in the MMP-treated group compared to the control and MTBE-treated groups.